StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN)

Analysts at StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN) in a research report issued on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock.

Separately, Alliance Global Partners reiterated a “buy” rating on shares of Evogene in a research note on Friday, March 7th.

Evogene Trading Down 1.1 %

Shares of EVGN opened at $1.38 on Wednesday. The firm has a market cap of $7.38 million, a PE ratio of -0.31 and a beta of 1.28. The firm has a fifty day simple moving average of $1.50 and a two-hundred day simple moving average of $1.87. Evogene has a 1-year low of $1.20 and a 1-year high of $9.00.

Evogene (NASDAQ:EVGN) last issued its quarterly earnings data on Thursday, March 6th. The biotechnology company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.72) by $0.78. Evogene had a negative return on equity of 109.05% and a negative net margin of 314.43%. The company had revenue of $1.61 million during the quarter, compared to analyst estimates of $3.63 million. During the same quarter in the previous year, the company posted ($1.30) earnings per share.

Hedge Funds Weigh In On Evogene

A hedge fund recently bought a new stake in Evogene stock. Jane Street Group LLC acquired a new position in Evogene Ltd. (NASDAQ:EVGN) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 21,345 shares of the biotechnology company’s stock, valued at approximately $40,000. Jane Street Group LLC owned 0.40% of Evogene as of its most recent SEC filing. 10.40% of the stock is owned by institutional investors and hedge funds.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.